GBIO GBIO
$5.34
-6.97%
at last close
Analyst Consensus
- Consensus Rating
- Buy (3 Buy · 1 Hold · 0 Sell)
- Average Price Target
- $8.88
- Implied Upside
- +66.2%
- Price Target Range
- $5.00 – $15.00
- Analysts (12 mo)
- 4
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2025-12-16 | WedbushDavid Nierengarten |
Upgrades | Neutral → Outperform | $7 → $6 |
| 2025-12-16 | JefferiesEun Yang |
Downgrades | Buy → Hold | $11 → $5 |
| 2025-11-07 | NeedhamGil Blum |
Suspends | Buy | $15 |
| 2025-08-18 | Canaccord GenuityWhitney Ijem |
Maintains | Buy | $9 → $10 |
| 2025-08-13 | NeedhamGil Blum |
Reiterates | Buy | $15 |
| 2025-08-13 | WedbushDavid Nierengarten |
Downgrades | Outperform → Neutral | $7 |
| 2025-05-08 | NeedhamGil Blum |
Reiterates | Buy | $8 |
| 2025-04-10 | NeedhamGil Blum |
Reiterates | Buy | $8 |
| 2025-03-17 | Canaccord GenuityWhitney Ijem |
Maintains | Buy | $9 |
| 2025-03-14 | Citizens Capital MarketsSilvan Tuerkcan |
Reiterates | Market perform | — |
| 2025-03-14 | NeedhamGil Blum |
Reiterates | Buy | $8 |
| 2025-01-08 | NeedhamGil Blum |
Maintains | Buy | $10 → $8 |
| 2024-10-23 | NeedhamGil Blum |
Reiterates | Buy | $10 |
| 2024-08-08 | WedbushDavid Nierengarten |
Reiterates | Outperform | $5 |
| 2024-08-08 | NeedhamGil Blum |
Reiterates | Buy | $10 |
| 2024-05-14 | NeedhamGil Blum |
Reiterates | Buy | $10 |
| 2024-05-14 | WedbushDavid Nierengarten |
Reiterates | Outperform | $5 |
| 2024-04-10 | NeedhamGil Blum |
Reiterates | Buy | $10 |
| 2024-03-07 | WedbushDavid Nierengarten |
Reiterates | Outperform | $5 |
| 2024-03-07 | NeedhamGil Blum |
Maintains | Buy | $14 → $10 |
| 2023-11-10 | WedbushDavid Nierengarten |
Maintains | Outperform | $11 → $9 |
| 2023-10-23 | JMP SecuritiesSilvan Tuerkcan |
Downgrades | Market outperform → Market perform | — |
| 2023-10-19 | TD CowenYaron Werber |
Downgrades | Outperform → Market perform | — |
| 2023-08-16 | JP MorganAnupam Rama |
Maintains | Neutral | $8 → $9 |
| 2023-08-03 | NeedhamGil Blum |
Reiterates | Buy | $14 |
| 2023-08-03 | WedbushDavid Nierengarten |
Reiterates | Outperform | $11 |
| 2023-05-11 | NeedhamGil Blum |
Reiterates | Buy | $14 |
| 2023-04-19 | NeedhamGil Blum |
Reiterates | Buy | $14 |
| 2023-03-24 | JMP SecuritiesSilvan Tuerkcan |
Reiterates | Market outperform | $7 |
| 2023-03-23 | NeedhamGil Blum |
Reiterates | Buy | $14 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $5.34
- Market Cap
- —
- 52-Week Range
- $3.65 – $6.95
- Average Volume
- 109K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.